drugset / Trial / NCT00116285

Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

NCT00116285 ↗

Phase 1 Completed 12 enrolled Allergy Therapeutics
Non-randomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the residual allergenicity of the modified ragweed pollen in Ragweed MATA MPL (modified pollen allergen tyrosine adsorbate + Monophosphoryl Lipid A) by skin prick testing. This is done by a comparison of the wheal response after skin prick testing with different concentrations of aqueous native allergen, modified allergen, modified tyrosine adsorbed allergen, and Ragweed MATA MPL.

Timeline

Start
2005-06
Primary completion
—
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject RagweedMATAMPL Other / unclassified — —